We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

April 13, 2011

AbbVie Biotechnology Limited v. The Mathilda and Terence Kennedy Institute of Rheumatology Trust

Track this case

Case Number:



New York Southern

Nature of Suit:



Paul A. Crotty



Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. June 26, 2013

    AbbVie Gets Humira Patent Invalidated As Obvious

    AbbVie Inc. has won a ruling in New York federal court declaring invalid a patent for the anti-inflammatory drug Humira held by the Mathilda and Terence Kennedy Institute of Rheumatology Trust, meaning the drugmaker no longer will have to pay the trust licensing fees.

1 other articles on this case. View all »


To view the parties, register now.